Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lanreotide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate 38mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 60mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 90mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 120mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate 30mg/vial injection suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 60mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 90mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 120mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate (substance) |
Is a |
False |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate (substance) |
Is modification of (attribute) |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial |
Has basis of strength substance (attribute) |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lanreotide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lanreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lanreotide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lanreotide (as lanreotide acetate) 180 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lanreotide (as lanreotide acetate) 120 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lanreotide (as lanreotide acetate) 240 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Lanreotide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |